IRIS
FRONTONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.490
AS - Asia 3.254
EU - Europa 2.618
SA - Sud America 364
AF - Africa 50
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 11
Totale 34.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.420
SG - Singapore 1.744
CN - Cina 556
DE - Germania 404
RU - Federazione Russa 388
UA - Ucraina 386
BR - Brasile 308
IT - Italia 308
IE - Irlanda 287
HK - Hong Kong 283
VN - Vietnam 269
SE - Svezia 184
GB - Regno Unito 170
FR - Francia 161
FI - Finlandia 110
PL - Polonia 83
JP - Giappone 79
KR - Corea 79
IN - India 51
CA - Canada 37
AR - Argentina 32
NL - Olanda 31
ID - Indonesia 28
TR - Turchia 28
BD - Bangladesh 23
MX - Messico 23
AT - Austria 19
IQ - Iraq 18
ES - Italia 16
ZA - Sudafrica 15
BE - Belgio 13
CZ - Repubblica Ceca 11
UZ - Uzbekistan 11
EU - Europa 10
AE - Emirati Arabi Uniti 9
PK - Pakistan 9
RO - Romania 9
AU - Australia 8
KE - Kenya 8
PH - Filippine 8
TH - Thailandia 8
EC - Ecuador 6
IL - Israele 6
KG - Kirghizistan 6
LT - Lituania 6
MY - Malesia 6
VE - Venezuela 6
CH - Svizzera 5
EG - Egitto 5
JO - Giordania 5
MD - Moldavia 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
ET - Etiopia 3
IR - Iran 3
MA - Marocco 3
NG - Nigeria 3
NP - Nepal 3
PY - Paraguay 3
TZ - Tanzania 3
BB - Barbados 2
CR - Costa Rica 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PE - Perù 2
PT - Portogallo 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
Totale 34.791
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.791
Wilmington 7.440
Houston 6.469
Fairfield 946
Singapore 857
Ann Arbor 623
Ashburn 594
Chandler 579
Seattle 339
Jacksonville 331
Cambridge 297
San Jose 285
Hong Kong 280
Dublin 259
Beijing 230
Medford 202
Dearborn 186
New York 127
Santa Clara 120
The Dalles 109
Los Angeles 106
Lawrence 91
Rome 76
Council Bluffs 75
Ho Chi Minh City 73
Tokyo 71
Hanoi 67
Buffalo 62
Kraków 61
Dallas 52
Lauterbourg 49
Moscow 41
Menlo Park 38
Helsinki 36
São Paulo 36
Mülheim 35
Nuremberg 34
San Diego 32
Milan 31
Boardman 28
Munich 28
Falls Church 27
London 24
Frankfurt am Main 22
Palo Alto 22
Nanjing 21
Jakarta 20
Boston 19
Orem 19
Phoenix 19
Redwood City 19
Zhengzhou 19
Norwalk 18
Mountain View 17
San Mateo 17
Dong Ket 16
Guangzhou 16
Haiphong 16
Warsaw 16
Brooklyn 15
Chennai 15
Chicago 15
Columbus 15
Redondo Beach 14
Brussels 13
Montreal 13
Verona 13
Chengdu 12
Kunming 12
Nürnberg 12
Shanghai 12
Atlanta 11
Brno 11
Indiana 10
Manchester 10
San Francisco 10
Ankara 9
Da Nang 9
Hefei 9
Mexico City 9
Seoul 9
Stockholm 9
Toronto 9
University Park 9
Detroit 8
Hangzhou 8
Johannesburg 8
Auburn Hills 7
Baghdad 7
Bangkok 7
Belo Horizonte 7
Brasília 7
Creede 7
Nairobi 7
Poplar 7
Rio de Janeiro 7
Campinas 6
Nanchang 6
Saint Petersburg 6
Bengaluru 5
Totale 29.928
Salva come PNG Salva come JPEG
Nome #
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 552
Insulin clearance is associated with carotid artery intima-media thickness 548
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 530
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients 507
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 499
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 496
The social burden of hypoglycemia in the elderly 480
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 477
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 471
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 470
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects 466
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 465
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 464
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 463
Preliminary evidence that obese patients with obstructive sleep apnea/hypopnea syndrome are refractory to the acute beneficial metabolic effects of a very low calorie diet 463
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 458
Acute caloric restriction improves glomerular filtration rate in patients with morbid obesity and type 2 diabetes 452
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases [Linee Guida per la concessione dell'idoneità all'attività sportiva ed il monitoraggio degli atleti affetti da malattie del sistema endocrino] 449
Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients 448
Carbohydrate metabolism in hypertension: influence of treatment 448
Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes 443
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 441
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 441
Comment on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379. 439
Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes 436
Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability 434
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes 430
The DAWN Youth WebTalk Study: methods, findings, and implications. 428
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 428
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 425
Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats 423
Methods of investigation for cardiac autonomic dysfunction in human research studies 423
Acute hyperglycemia reduces cerebrovascular reactivity: The role of glycemic variability 420
Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. 418
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 416
Evaluation of guidelines on diabetes medication. 415
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C 413
Hyperinsulinaemia in offspring of Type 2 diabetic patients: impaired response of carbohydrate metabolism, but preserved cardiovascular response 412
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 412
The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients 411
Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. 404
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database 401
Comment on: Kromhout et al. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. 400
SYMPTOMATIC TREATMENT OF AUTONOMIC NEUROPATHY IN DIABETIC SUBJECTS 399
Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease 399
Single retinal layer evaluation in patients with type 1 diabetes with no or early signs of diabetic retinopathy: The first hint of neurovascular crosstalk damage between neurons and capillaries? 399
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint 398
Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography 394
Glucose variability: An emerging target for the treatment of diabetes mellitus 392
The need for identifying standardized indices for measuring glucose variability. 389
Bariatric surgery or medical therapy for obesity 388
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 388
Effect of the GSTM1 gene deletion on glycemic variability, sympatho-vagal balance and arterial stiffness in patients with metabolic syndrome, but without diabetes 386
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 383
Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit. 381
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 380
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients 379
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes 374
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 374
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 374
Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association? 371
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases 368
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women 366
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 361
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. 356
QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA 355
Correspondence between the international diabetes federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic caucasians: The GISIR database [4] 349
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 347
Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus 337
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 335
Effects of insulin on cholesterol synthesis in type II diabetes patients 334
Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels 329
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 321
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes 314
La terapia insulinica aumenta il rischio cardiovascolare? 303
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 302
Activation of retinal Müller cells in response to glucose variability 282
Flavonoids and insulin-resistance: from molecular evidences to clinical trials 278
Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome 267
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 266
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 263
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 262
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 248
Early alterations of corneal subbasal plexus in uncomplicated type 1 diabetes patients 201
Neuropathic damage in the diabetic eye: clinical implications 201
Urban diabetes: the case of the metropolitan area of Rome 184
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 133
Urban diabetes: the case of the metropolitan area of Rome 131
Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery 111
Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System 98
The evaluation of tactile dysfunction in the hand in type 1 diabetes: a novel method based on haptics 95
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes 90
Glycemic status assessment by the latest glucose monitoring technologies 90
Subcutaneous insulin infusion (CSII) in italy: The third national survey 79
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 77
Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations 71
Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-determination: the Italian Road to Bariatric Surgery 71
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 70
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance 67
Knowledge, experiences, and perceptions relating to obesity management among primary care physicians in the Lazio Region, Italy 53
Totale 35.032
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.782
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021376 0 0 0 0 0 0 0 0 0 107 180 89
2021/20221.009 38 106 75 46 52 105 44 55 47 93 53 295
2022/20231.406 137 107 68 186 150 298 123 80 149 3 65 40
2023/2024361 38 12 29 12 39 111 27 17 6 9 5 56
2024/20252.453 104 510 251 131 53 105 200 112 199 137 324 327
2025/20263.292 338 199 465 286 286 113 429 449 421 306 0 0
Totale 35.049